Clinical Trial Update: Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RNS60 for pain and function after knee anterior cruciate ligament reconstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Reconstruction

Drugs mentioned

• RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Anterior Cruciate Ligament Reconstruction | Phase 2 | Status: WITHDRAWN